[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.189.139. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
July 2008

Notice of Failure to Disclose Financial Interest: “A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials” (Arch Neurol. 2007;64[9]:1323-1329)

Arch Neurol. 2008;65(7):992-996. doi:10.1001/archneur.65.7.992-b

A matter has come to my attention that I would appreciate having the opportunity of addressing through the pages of the Archives. The issue relates to our article1 on the neuropsychological test battery (NTB) published in September 2007 and my consulting relationship with Elan Pharmaceuticals and Wyeth Research. Let me begin by clarifying my financial position regarding the NTB:

First Page Preview View Large
First page PDF preview
First page PDF preview
×